MedSelect, Inc., a leading player in the healthcare technology sector, is headquartered in the United States and operates extensively across North America. Founded in 2005, the company has established itself as a pioneer in medical supply chain management and healthcare logistics, providing innovative solutions that enhance operational efficiency for healthcare providers. MedSelect's core offerings include advanced inventory management systems and data analytics tools, designed to optimise resource allocation and reduce costs. What sets MedSelect apart is its commitment to integrating cutting-edge technology with user-friendly interfaces, ensuring seamless adoption by healthcare professionals. With a strong market position, MedSelect has garnered recognition for its contributions to improving patient care and operational workflows. The company continues to expand its footprint, striving to lead the way in transforming healthcare logistics for a more efficient future.
How does MedSelect, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MedSelect, Inc.'s score of 27 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MedSelect, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Cencora, Inc., from which it inherits emissions data and climate commitments. As of now, MedSelect, Inc. has not established any documented reduction targets or climate pledges. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing its climate strategy. Given its relationship with Cencora, Inc., any future emissions data or climate commitments may be influenced by the sustainability initiatives and targets set by Cencora. This includes potential alignment with industry standards such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are also cascaded from Cencora, Inc. In summary, while MedSelect, Inc. currently lacks specific emissions data and reduction targets, its affiliation with Cencora, Inc. may provide a pathway for future climate commitments and performance improvements.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2024 | |
|---|---|---|
| Scope 1 | 98,742,000 | 000,000,000 |
| Scope 2 | 110,191,000 | 00,000,000 |
| Scope 3 | 19,881,916,000 | 00,000,000,000 |
MedSelect, Inc.'s Scope 3 emissions, which increased by 104% last year and increased by approximately 104% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the primary emissions source at 1% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MedSelect, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.